Cytel Brochures

11. Quantitative Pharmacology and Pharmacometrics Brochure 10/31/2018

    Exposure and dose response analyses, including pharmacokinetic and pharmacodynamics analyses, guide critical decisions in drug development. Cytel’s expert Quantitative Pharmacology and Pharmacometrics group helps our customers get those decisions right.

12. Cytel East Architect Brochure 10/31/2018

    Successful studies begin with the right design. East is the industry standard for designing adequate and well-controlled clinical trials as per FDA and EMA guidance. Since its introduction in 1994, East has reliably and continuously enabled drug and medical device trial sponsors of all sizes to optimize their trial planning and monitoring efforts.

13. EnForeSys Enrollment Forecasting Software Brochure 10/31/2018

    Today, more than half of clinical studies take longer than expected to achieve their enrollment targets, often leading to discontinued trials, and expensive failures. EnForeSys is a user-friendly decision tool that leverages cutting-edge simulation methods to predict recruitment milestones with high accuracy. Armed with a reliable probability of success, you can rest assured that your trial will achieve its target enrollment on time and on budget.

14. Cytel Services Brochure 10/31/2018

    Cytel is committed to improving the quality, analysis and interpretation of data for clinical development. Founded by world-renowned biostatisticians and Fellows of the American Statistical Association, Cytel maintains a tradition of leadership in statistical innovation. Our team is dedicated to improving the probability of clinical trial success and helping to deliver new medicines to the patients who need them.